Resveratrol stimulates AMP kinase activity in neurons
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Resveratrol is a polyphenol produced by plants that has multiple beneficial activities similar to those associated with caloric restriction (CR), such as increased life span and delay in the onset of diseases associated with aging. CR improves neuronal health, and the global beneficial effects of CR have been postulated to be mediated by the nervous system. One key enzyme thought to be activated during CR is the AMP-activated kinase (AMPK), a sensor of cellular energy levels. AMPK is activated by increases in the cellular AMP:ATP ratio, whereupon it functions to help preserve cellular energy. In this regard, the regulation of dietary food intake by hypothalamic neurons is mediated by AMPK. The suppression of nonessential energy expenditure by activated AMPK along with the CR mimetic and neuroprotective properties of resveratrol led us to hypothesize that neuronal activation of AMPK could be an important component of resveratrol activity. Here, we show that resveratrol activated AMPK in Neuro2a cells and primary neurons in vitro as well as in the brain. Resveratrol and the AMPK-activating compound 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) promoted robust neurite outgrowth in Neuro2a cells, which was blocked by genetic and pharmacologic inhibition of AMPK. Resveratrol also stimulated mitochondrial biogenesis in an AMPK-dependent manner. Resveratrol-stimulated AMPK activity in neurons depended on LKB1 activity but did not require the NAD-dependent protein deacetylase SIRT1 during this time frame. These findings suggest that neuronal activation of AMPK by resveratrol could affect neuronal energy homeostasis and contribute to the neuroprotective effects of resveratrol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Resveratrol treatment activates SIRT1, PGC-1α and AMPK [29, 145-148] and inhibits AKT [149] (Figure 4).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [148]
Citations
Cites
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Mäkelä, T. P., Alessi, D. R., & Hardie, D. G. (2003) · Journal of Biology · doi:10.1186/1475-4924-2-28 · Cited by 1,665
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M. J., et al. (2004) · Nature · doi:10.1038/nature02440 · Cited by 1,637
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Woods, A., Dickerson, K., Heath, R., Hong, S.-P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,392
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107
Cited by
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
“The mammalian AMPK domain limits were established experimentally by partial proteolysis (395), and a stable rat 1(68-163) fragment was expressed and crystallized in the presence of -cyclodextrin (an 1-4 linked heptaglucan), as had previously been performed for other starch binding domain structural studies (396).”
BackgroundMethodInfluentialPrice, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602
“We and others have shown that resveratrol activates AMPK in cell culture and in vivo (Baur et al., 2006; Dasgupta and Milbrandt, 2007), and a study of AMPK knockout mice established that AMPK is required for many of the beneficial effects of resveratrol onmetabolic function (Umet al.”
BackgroundResveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Dietary polyphenols and their biological significance
Han, X., Shen, T., & Lou, H. (2007) · International Journal of Molecular Sciences · doi:10.3390/i8090950 · Cited by 1,081
“Resveratrol had an impact on cognitive deficits by activating the phosphorylation of protein kinase C (PKC), secreting transthyretin to prevent Aβ aggregation in cultured rat hippocampal cells [77], and stimulating AMP kinase activity in Neuro2a cells and primary neurons [75].”
BackgroundResources and Biological Activities of Natural Polyphenols
Li, A.-N., Li, S., Zhang, Y.-J., Xu, X.-R., Chen, Y.-M., & Li, H.-B. (2014) · Nutrients · doi:10.3390/nu6126020 · Cited by 883
AMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903
Fulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., & Sartorelli, V. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.004 · Cited by 820
“Finally, the SIRT1 agonist resveratrol- shown to augment survival of mice on a high-calorie diet (Baur et al., 2006) and improve mitochondrial function (Lagouge et al., 2006) - induces phosphorylation and activation of AMPK (Baur et al., 2006) (Dasgupta and Milbrandt, 2007).”
BackgroundSIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825
SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802187200 · Cited by 778
Luen Tang, B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2318 · Cited by 740
“The work of Dasgupta and Milbrandt indicates that resveratrol could directly activate AMPK, at least in certain cell types, in a manner that is completely independent of Sirt1 activity (Dasgupta and Milbrandt, 2007).”
BackgroundSirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism
Nogueiras, R., Habegger, K. M., Chaudhary, N., Finan, B., Banks, A. S., Dietrich, M. O., Horvath, T. L., Sinclair, D. A., Pfluger, P. T., & Tschöp, M. H. (2012) · Physiological Reviews · doi:10.1152/physrev.00022.2011 · Cited by 711
“Resveratrol has been shown to be an indirect activator of several proteins such as AMPK, an important enzyme for energy and glucose homeostasis (34, 70, 84, 146, 244, 296, 332).”
BackgroundFeige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719
“In addition, we evaluated the action of SRT1720 on AMPK, which has been demonstrated to be activated by resveratrol independently of SIRT1 (Baur et al., 2006; Dasgupta and Milbrandt, 2007).”
BackgroundRegulation of SIRT1 in cellular functions: Role of polyphenols
Chung, S., Yao, H., Caito, S., Hwang, J.-W., Arunachalam, G., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.003 · Cited by 650
Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 645
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
“(12) showed that, at lower doses, resveratrol can activate AMPK through a Sirt1-independent manner.”
BackgroundTranscriptional Control of Mitochondrial Biogenesis and Function
Hock, M. B., & Kralli, A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163119 · Cited by 614
“Besides SIRT1, resveratrol may also activate AMPK (160).”
BackgroundAging and Survival: The Genetics of Life Span Extension by Dietary Restriction
Mair, W., & Dillin, A. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061206.171059 · Cited by 603
Greer, E. L., & Brunet, A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00459.x · Cited by 572
“Resveratrol has recently been found to activate AMPK in cultured cells and in mice (Baur et al., 2006; Zang et al., 2006; Dasgupta & Milbrandt, 2007; Hwang et al., 2007).”
BackgroundEffects of Flavonoids and other Polyphenols on Inflammation
González, R., Ballester, I., López-Posadas, R., Suárez, M. D., Zarzuelo, A., Martínez-Augustin, O., & Medina, F. S. D. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903584094 · Cited by 569
“In addition, resveratrol has well known neuroprotective effects, which are due to AMPK activation (Dasgupta and Milbrandt 2007).”
BackgroundBarger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002264 · Cited by 580
“Other proposed biochemical mechanisms of action of resveratrol that were not examined in this study may include stimulation of AMP kinase [35], and increased nitric oxide synthase activity [36–38].”
BackgroundNAD + metabolism: Bioenergetics, signaling and manipulation for therapy
Yang, Y., & Sauve, A. A. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.014 · Cited by 497
“Resveratrol has since been appreciated to have complex effects, including activation of AMPK [124] as well as potentiation of cAMP signaling [125].”
BackgroundDzeja, P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 475
“that troglitazone-induced increases in phosphorylated forms of AMPK and ACC are paralleled by an increase in the AMP-to-ATP ratio [193].”
BackgroundViollet, B., Guigas, B., Leclerc, J., Hébrard, S., Lantier, L., Mounier, R., Andreelli, F., & Foretz, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01970.x · Cited by 486
“Furthermore, AMPK activation by resveratrol-activated SIRT1 is mediated by the upstream kinase, LKB1, but not CaMKKb.”
BackgroundInfluentialResveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease
Wu, Y., Li, X., Zhu, J. X., Xie, W., Le, W., Fan, Z., Jankovic, J., & Pan, T. (2011) · Neurosignals · doi:10.1159/000328516 · Cited by 492
Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.-L., Beal, M. F., & Gibson, G. E. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.008 · Cited by 485
“Other reports suggest that resveratrol has other SIRT 1 independent actions (Dasgupta and Milbrandt, 2007).”
BackgroundAMPK and the biochemistry of exercise: implications for human health and disease
Richter, E. A., & Ruderman, N. B. (2009) · Biochemical Journal · doi:10.1042/bj20082055 · Cited by 481
“However, recent studies have indicated that SIRT1 expression is increased after both a single prolonged bout of exercise [187] as well as after physical training [40].”
BackgroundInfluentialThe molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477
“By early 2007 several labs reported that Rsv had the ability to activate AMPK [45,68,69].”
BackgroundAMPK activation: a therapeutic target for type 2 diabetes?
Saha, A., Coughlan, K., Valentine, R., & Ruderman, N. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s43731 · Cited by 429
“Resveratrol has been shown to stimulate AMPK activity in multiple cell types, including hepatocytes, muscle cells,(119,120) and neurons.(121) The mechanism by which resveratrol activates AMPK is thought to be an increase in AMP levels due to inhibition of the mitochondrial F1 ATPase.”
Hardeland, R., Madrid, J. A., Tan, D., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00934.x · Cited by 448
Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans
Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., & Partridge, L. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.07.007 · Cited by 435
“Resveratrol acts on a number of target proteins (Baur and Sinclair, 2006); for example it was recently shown to activate AMP kinase and have neuroprotective properties, but this effect is Sir2-independent (Dasgupta and Milbrandt, 2007).”
BackgroundDietary Polyphenol, Gut Microbiota, and Health Benefits
Wang, X., Qi, Y., & Zheng, H. (2022) · Antioxidants · doi:10.3390/antiox11061212 · Cited by 376
“Resveratrol can activate the phosphorylation of protein kinase C and secretes transthyretin to prevent Aβ aggregation in cultured rat hippocampal cells [34].”
BackgroundTargeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
Cantó, C., & Auwerx, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003905 · Cited by 433
“Cantó et al. (2009) described how the phosphorylation of PGC-1 by AMPK in situations of energy stress is required to prime it for subsequent deacetylation and activation by SIRT1.”
InfluentialLee, H., Lee, Y. J., Choi, H., Ko, E. H., & Kim, J.-W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808742200 · Cited by 426
Sirtuins — novel therapeutic targets to treat age-associated diseases
Lavu, S., Boss, O., Elliott, P. J., & Lambert, P. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2665 · Cited by 426
“For example, resveratrol stimulates AMP-dependent protein kinase (AMPK) activity in neuron”
BackgroundResveratrol is not a direct activator of SIRT1 enzyme activity
Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S., Atangan, L., & Wang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00901.x · Cited by 426
Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al‐Abed, Y., Davies, P., & Marambaud, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07594.x · Cited by 426
“The exact Abbreviations used: AD, Alzheimer’s disease; APP, amyloid precursor protein; Ab, amyloid-b; HFIP, Hexa-Fluor-2-Propanol; IKK, IjB kinase; IL, interleukin; IRF3, interferon regulatory factor 3; LPS, lipopolysaccharide; MyD88, myeloid differentiation primary response gene 88; NF-jB, nuclear factor j-light-chai…”
BackgroundInfluentialNeuroprotective action of resveratrol
Bastianetto, S., Ménard, C., & Quirion, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 407
Pillai, V. B., Sundaresan, N. R., Kim, G., Gupta, M., Rajamohan, S. B., Pillai, J. B., Samant, S., Ravindra, P. V., Isbatan, A., & Gupta, M. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077271 · Cited by 419
Conserved Metabolic Regulatory Functions of Sirtuins
Schwer, B., & Verdin, E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.006 · Cited by 415
Resveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 405
Yang, Z., Kahn, B. B., Shi, H., & Xue, B.-Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123620 · Cited by 410
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
“Nevertheless, Dasgupta andMilbrandt show that resveratrol is a potent activator of AMP-activated protein kinase (AMPK) function, and resveratrol-mediated AMPK activation was independent of SIRT1 [114].”
BackgroundSIRT1 Negatively Regulates the Mammalian Target of Rapamycin
Ghosh, H. S., McBurney, M., & Robbins, P. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009199 · Cited by 397
“Resveratrol has been shown to activate the AMP-activated kinase (AMPK) pathway independent of SIRT1 [28,29].”
BackgroundCaloric restriction, SIRT1 and longevity
Cantó, C., & Auwerx, J. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.03.008 · Cited by 395
“Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.”
InfluentialTen years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases
Imai, S.-I., & Guarente, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.003 · Cited by 390
Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391
Are sirtuins viable targets for improving healthspan and lifespan?
Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G., & de Cabo, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3738 · Cited by 382
Puissant, A., Robert, G., Fenouille, N., Luciano, F., Cassuto, J.-P., Raynaud, S., & Auberger, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3537 · Cited by 374
“It has been proposed that RSV might transduce part of its effect through AMPK activation (29, 30).”
BackgroundSeven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
“atrol can activate AMPK in tissue from SIRT1 knockout mice [267,270], it is unable to activate SIRT1 in the absence of functional AMPK [270,277].”
BackgroundSarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions
Gerdts, J., Summers, D. W., Sasaki, Y., DiAntonio, A., & Milbrandt, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1197-13.2013 · Cited by 375
“Neither DIO-SAM-TIR nor Cre lentiviruses are toxic to neurons, but when combined these viruses promote robust axon degeneration (Fig.”
BackgroundSelf-citationPhillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/3589271 · Cited by 327
“Recently, it has garnered increased attention amidst reports of its neuroprotective and antiamyloid properties [305, 306] in rodents through mechanisms that likely involve oxidative stress [306], energy homeostasis [307], and neural plasticity [308, 309].”
BackgroundMitochondrial biogenesis and healthy aging
López-Lluch, G., Irusta, P. M., Navas, P., & de Cabo, R. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.014 · Cited by 364
“Recently we and others demonstrated that a CR mimetic, the polyphenol resveratrol, affects mitochondrial biogenesis in liver, muscle and brain (Baur, et al., 2006; Dasgupta & Milbrandt, 2007; Lagouge, et al., 2006).”
BackgroundInfluentialDevelopment of protein kinase activators: AMPK as a target in metabolic disorders and cancer
Fogarty, S., & Hardie, D. G. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.012 · Cited by 350
Ralph, S. J., Rodríguez-Enríquez, S., Neuzil, J., Saavedra, E., & Moreno-Sánchez, R. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.008 · Cited by 331
“This activation of AMPK does not involve SIRT1 but requires activation of the upstream kinase, LKB1 (Dasgupta and Milbrandt, 2007).”
BackgroundResveratrol as a Therapeutic Agent for Neurodegenerative Diseases
Sun, A. Y., Wang, Q., Simonyi, A., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8111-y · Cited by 329
“The neuronal activation of AMPK by resveratrol could affect neuronal energy homeostasis and contribute to the neuroprotective effects of resveratrol.”
Modulation of endogenous antioxidant system by wine polyphenols in human disease
Rodrigo, R., Miranda, A., & Vergara, L. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.034 · Cited by 306
Aging and disease: connections to sirtuins
Donmez, G., & Guarente, L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00548.x · Cited by 311
“As resveratrol has been proposed to affect targets in addition to SIRT1 (Dasgupta & Milbrandt, 2007), it is important to consider newer classes of SIRT1 activators that may be more specific.”
BackgroundSrivastava, R. A. K., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., & Newton, R. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r025882 · Cited by 296
“Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells.”
BackgroundInfluentialMudò, G., Mäkelä, J., Liberto, V. D., Tselykh, T. V., Olivieri, M., Piepponen, P., Eriksson, O., Mälkiä, A., Bonomo, A., Kairisalo, M., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0850-z · Cited by 301
“Previous studies have shown that RSV counteracts cell stress and activates PGC-1a as well as AMP kinase in neurons [13, 39].”
BackgroundZu, Y., Liu, L., Lee, M. Y. K., Xu, C., Liang, Y., Man, R. Y., Vanhoutte, P. M., & Wang, Y. (2010) · Circulation Research · doi:10.1161/circresaha.109.215483 · Cited by 303
Vingtdeux, V., Davies, P., Dickson, D. W., & Marambaud, P. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0759-x · Cited by 296
“Furthermore, mild caloric restriction, exercise, or treatments with the hormone leptin or with the natural polyphenol resveratrol (four interventions known to activate AMPK) were found to prevent different neurodegenerative mechanisms in cell culture systems or mouse models [7, 8, 16, 41].”
Reinisalo, M., Kårlund, A., Koskela, A., Kaarniranta, K., & Karjalainen, R. O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/340520 · Cited by 284
“Importantly, resveratrol was able to activate AMPK in neuronal cells in vitro as well as in the brain and it enhanced activation of mitochondrial biogenesis in an AMPK-dependent manner [268].”
BackgroundBraidy, N., Berg, J., Clement, J., Khorshidi, F., Poljak, A., Jayasena, T., Grant, R., & Sachdev, P. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7269 · Cited by 275
“However, recent reports have challenged this ‘‘direct activation’’ hypothesis, suggesting that the mechanism by which resveratrol increases SIRT1 function is still unknown (39, 86).”
ResultTargeting the AMPK pathway for the treatment of Type 2 diabetes
Viollet, B. (2009) · Frontiers in Bioscience · doi:10.2741/3460 · Cited by 278
“It should be noted that the regulation of LKB1/AMPK signaling by SIRT1 is probably tissue-specific as resveratrol-stimulated AMPK activation is independent of SIRT1 in neurons (99).”
Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
Park, D., Jeong, H., Lee, M. N., Koh, A., Kwon, O., Yang, Y. R., Noh, J., Suh, P.-G., Park, H., & Ryu, S. H. (2016) · Scientific Reports · doi:10.1038/srep21772 · Cited by 281
Calorie Restriction: Is AMPK a Key Sensor and Effector
Cantó, C., & Auwerx, J. (2011) · Physiology · doi:10.1152/physiol.00010.2011 · Cited by 282
“Rsv had the ability to activate AMPK (8, 20, 116).”
DNA replication stress, genome instability and aging
Burhans, W. C., & Weinberger, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1059 · Cited by 279
“Inhibition of proliferation by AMPK has been implicated in the neuroprotective effects of both caloric restriction and resveratrol, a plant polyphenol that mimics caloric restriction and inhibits aging in yeast and mice (57).”
BackgroundNatural polyphenols against neurodegenerative disorders: Potentials and pitfalls
Ebrahimi, A., & Schluesener, H. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.006 · Cited by 270
“Resveratrol AMPK signaling pathway Dasgupta and Milbrandt (2007)”
BackgroundBrookins Danz, E. D., Skramsted, J., Henry, N., Bennett, J. A., & Keller, R. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.011 · Cited by 266
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
SHANG, J., CHEN, L.-L., XIAO, F.-X., SUN, H., DING, H.-C., & XIAO, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00807.x · Cited by 274
Baxter, R. A. (2008) · Journal of Cosmetic Dermatology · doi:10.1111/j.1473-2165.2008.00354.x · Cited by 263
Sirtuins, Cell Senescence, and Vascular Aging
Kida, Y., & Goligorsky, M. S. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.022 · Cited by 256
Chen, L., Xu, B., Liu, L., Luo, Y., Zhou, H., Chen, W., Shen, T., Han, X., Kontos, C. D., & Huang, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.032 · Cited by 251
“For example, the AMPK-activating agent AICAR protected hippocampal neurons against death induced by glucose deprivation, chemical hypoxia, and exposure to glutamate and amyloid β-peptide, implying that AMPK activation may play a protective role against stress in neuronal cells [50].”
BackgroundAMP-activated protein kinase, stress responses and cardiovascular diseases
Wang, S., Song, P., & Zou, M.-H. (2012) · Clinical Science · doi:10.1042/cs20110625 · Cited by 245
Hippocampal Sirtuin 1 signaling mediates depression-like behavior
Abe-Higuchi, N., Uchida, S., Yamagata, H., Higuchi, F., Hobara, T., Hara, K., Kobayashi, A., & Watanabe, Y. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.009 · Cited by 247
Uittenbogaard, M., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 239
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246
“, The fact that AMPK is activated by resveratrol in SIRT1 defective cells and that defective AMPK activity compromises resveratrol-induced SIRT1 activation (Canto et al., 2010; Dasgupta and Milbrandt, 2007; Um et al., 2010), indicates that AMPK might be the initial trigger of this signal loop.”
BackgroundResveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802869200 · Cited by 244
Pasinetti, G. M., Wang, J., Ho, L., Zhao, W., & Dubner, L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.006 · Cited by 239
“Resveratrol is a relatively potent activator of AMPK in cell cultures and in vivo in mice (Cantó & Auwerx, 2009; Vingtdeux, et al., 2010; Dasgupta & Milbrandt, 2007; Hawley, et al., 2010).”
BackgroundFerretta, A., Gaballo, A., Tanzarella, P., Piccoli, C., Capitanio, N., Nico, B., Annese, T., Di Paola, M., Dell'Aquila, C., De Mari, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.02.010 · Cited by 243
“Resveratrol is a relatively strong activator of AMPK, a wellestablished sensor of low metabolic fuel in cell cultures and in animal model [16,50–53].”
BackgroundResultEffects of Resveratrol and SIRT1 on PGC-1α Activity and Mitochondrial Biogenesis: A Reevaluation
Higashida, K., Kim, S. H., Jung, S. R., Asaka, M., Holloszy, J. O., & Han, D.-H. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001603 · Cited by 228
“In studies on the effects of resveratrol on cells in culture, concentrations in the 30 mM to 100 mM range have routinely been used [3,12,14,15].”
MethodModulation of neurotrophic signaling pathways by polyphenols
Firuzi, O., Moosavi, F., Hosseini, R., & Saso, L. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s96936 · Cited by 221
Rapidly Increased Neuronal Mitochondrial Biogenesis After Hypoxic-Ischemic Brain Injury
Yin, W., Signore, A. P., Iwai, M., Cao, G., Gao, Y., & Chen, J. (2008) · Stroke · doi:10.1161/strokeaha.108.520114 · Cited by 234
Therapeutic potential of resveratrol in Alzheimer's disease
Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., & Marambaud, P. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s6 · Cited by 224
“In line with these studies, resveratrol appears to be protective against the dysregulation of energy homeostasis observed in mouse models for metabolic syndromes by a mechanism implicating the activation of SIRT1, PGC-1α, and the energy sensor protein kinase AMPK (AMP-activated protein kinase) [23-25].”
BackgroundZheng, T., Yang, X., Wu, D., Xing, S., Bian, F., Li, W., Chi, J., Bai, X., Wu, G., Chen, X., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13120 · Cited by 221
“Adenine nucleotide measurements and mitochondrial membrane potential (Δψm) assay Cellular ATP and AMP levels were determined as described previously (Dasgupta and Milbrandt, 2007).”
MethodSirtuin deacetylases in neurodegenerative diseases of aging
Herskovits, A. Z., & Guarente, L. (2013) · Cell Research · doi:10.1038/cr.2013.70 · Cited by 219
Small-Molecule Allosteric Activators of Sirtuins
Sinclair, D. A., & Guarente, L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134657 · Cited by 223
“Several papers showed that resveratrol can activate AMPK in vivo (88, 107, 108), leading some researchers to speculate that resveratrol indirectly activates SIRT1 via AMPK.”
BackgroundSIRT1: Regulation of longevity via autophagy
Salminen, A., & Kaarniranta, K. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.014 · Cited by 221
AMP‐activated protein kinase: a potential player in Alzheimer’s disease
Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H., & Hiltunen, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07331.x · Cited by 222
“Dasgupta and Milbrandt (2007) demonstrated that resveratrol stimulated AMPK both in cultured neurons and in mouse brain and it also enhanced neurite outgrowth and mitochondrial biogenesis in cultured neurons.”
BackgroundMolecular mechanisms of the cardiovascular protective effects of polyphenols
Andriantsitohaina, R., Auger, C., Chataigneau, T., Étienne-Selloum, N., Li, H., Martínez, M. C., Schini-Kerth, V. B., & Laher, I. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512003406 · Cited by 213
“Polyphenols found in natural products can target and activate AMPK leading to numerous beneficial effects in cardiovascular and metabolic diseases, as shown by the finding that activation of AMPK by resveratrol is SIRT1-independent((138))”
BackgroundRoy Chowdhury, S. K., Smith, D. R., Saleh, A., Schapansky, J., Marquez, A., Gomes, S., Akude, E., Morrow, D., Calcutt, N. A., & Fernyhough, P. (2012) · Brain · doi:10.1093/brain/aws097 · Cited by 210
“Previous studies in Neuro-2a cells and embryonic sensory neurons have shown that resveratrol raised AMPK phosphorylation, enhanced markers of mitochondrial biogenesis and promoted neurite outgrowth via an LKB1-dependent but SIRT1-independent mechanism (Dasgupta and Milbrandt, 2007).”
BackgroundInfluentialResveratrol and Vascular Function
Li, H., Xia, N., Hasselwander, S., & Daiber, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092155 · Cited by 203
“, by reduction of the intracellular ATP level [17,18] or its deacetylation by SIRT1 [19,20].”
BackgroundRecent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
Protective effects and mechanisms of sirtuins in the nervous system
Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., & Chen, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.001 · Cited by 211
Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice
Xu, T.-T., Li, H., Dai, Z., Lau, G. K., Li, B.-Y., Zhu, W.-L., Liu, X.-Q., Liu, H.-F., Cai, W.-W., Huang, S.-Q., et al. (2020) · Aging · doi:10.18632/aging.103035 · Cited by 200
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
Dietrich, M. O., & Horvath, T. L. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3739 · Cited by 200
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Rahman, M. H., Akter, R., Bhattacharya, T., Abdel-Daim, M. M., Alkahtani, S., Arafah, M. W., Al-Johani, N. S., Alhoshani, N. M., Alkeraishan, N., Alhenaky, A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619024 · Cited by 193
Resveratrol, sirtuins, and the promise of a DR mimetic
Baur, J. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.02.007 · Cited by 196
Wang, R., Li, J. J., Diao, S., Kwak, Y.-D., Liu, L., Zhi, L., Büeler, H., Bhat, N. R., Williams, R. W., Park, E. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.016 · Cited by 197
Metadata
- Authors
- Dasgupta, B., & Milbrandt, J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-04-24
- Volume
- 104
- Issue
- 17
- Pages
- 7217-7222
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1855377
- OpenAlex
- W2096361448
- Cited by
- 723
- References
- 49
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 18 · 2023: 19 · 2022: 22 · 2021: 27 · 2020: 28 · 2019: 31 · 2018: 43 · 2017: 39 · 2016: 44 · 2015: 42 · 2014: 45 · 2013: 62 · 2012: 53
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hope Center for Neurological Disorders
- National Institutes of Health (AG13730, NS057105)
- National Institute on Aging (AG 13730, RF1AG013730, R56AG013730, R01AG013730)
- National Institute of Neurological Disorders and Stroke (NS39358, P30NS057105, NS057105, R01NS039358)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- resveratrol, AMPK, neurons, caloric restriction mimetics, neurite outgrowth, mitochondrial biogenesis, LKB1, SIRT1, neuroprotection, AICAR, N2a cells
- MeSH terms
- Resveratrol, Adenylate Kinase, Aminoimidazole Carboxamide, Animals, Brain, Enzyme Activation, Ganglia, Spinal, Male, Mitochondria, Neurons, Neurons, Afferent, Phosphorylation, Ribonucleotides, Stilbenes, Neurites, Protein Serine-Threonine Kinases, Sirtuins, Mice, AMP-Activated Protein Kinases, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.